ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $56.20 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-03
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $56.20M, a 36.64% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$98.70M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$77.40M, a 176.48% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $37.80M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was -$49.60M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was -$37.60M, a 131.70% decline from fiscal 2009.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was $118.60M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2008 was -$50.30M, a 162.02% decline from fiscal 2007.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $56.20M 10-Q · filed 2012-05-03 | -$42.50M derived: sum of 2 quarters · filed 2012-05-03 | -$119.90M derived: sum of 3 quarters · filed 2012-05-03 | -$82.10M derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-12-31 | -$98.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$176.10M derived: sum of 2 quarters · filed 2012-02-27 | -$138.30M derived: sum of 3 quarters · filed 2012-02-27 | -$49.60M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$77.40M 10-Q · filed 2011-11-02 | -$39.60M derived: sum of 2 quarters · filed 2011-11-02 | $49.10M 10-Q · filed 2011-11-02 | $44.80M derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-06-30 | $37.80M 10-Q · filed 2011-08-08 | $126.50M 10-Q · filed 2011-08-08 | $122.20M derived: sum of 3 quarters · filed 2012-05-03 | $223.40M derived: sum of 4 quarters · filed 2012-05-03 |
| 2011-03-31 | $88.70M 10-Q · filed 2012-05-03 | $84.40M derived: sum of 2 quarters · filed 2012-05-03 | $185.60M derived: sum of 3 quarters · filed 2012-05-03 | $104.80M derived: sum of 4 quarters · filed 2012-05-03 |
| 2010-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $96.90M derived: sum of 2 quarters · filed 2012-02-27 | $16.10M derived: sum of 3 quarters · filed 2012-02-27 | -$37.60M 10-K · filed 2012-02-27 |
| 2010-09-30 | $101.20M 10-Q · filed 2011-11-02 | $20.40M derived: sum of 2 quarters · filed 2011-11-02 | -$33.30M 10-Q · filed 2011-11-02 | -$25.90M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | -$80.80M 10-Q · filed 2011-08-08 | -$134.50M 10-Q · filed 2011-08-08 | -$127.10M derived: sum of 3 quarters · filed 2012-02-27 | -$58.30M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | -$53.70M 10-Q · filed 2011-05-05 | -$46.30M derived: sum of 2 quarters · filed 2012-02-27 | $22.50M derived: sum of 3 quarters · filed 2012-02-27 | $76.20M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $76.20M derived: sum of 2 quarters · filed 2012-02-27 | $129.90M derived: sum of 3 quarters · filed 2012-02-27 | $118.60M 10-K · filed 2012-02-27 |
| 2009-09-30 | $68.80M 10-Q · filed 2010-11-03 | $122.50M derived: sum of 2 quarters · filed 2010-11-03 | $111.20M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $53.70M 10-Q · filed 2010-08-05 | $42.40M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | -$50.30M 10-K · filed 2011-02-25 | |||
| 2007-12-31 | $81.10M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |